 |
3 Diseases |  |
0 Trials |
|
0 Trials |  |
21 News |  |
- ||| desoximetasone topical spray / Generic mfg.
Trial completion, Trial completion date: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Apr 24, 2020
P4, N=129, Completed, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2020
- || desoximetasone topical spray / Generic mfg.
Trial completion date, Trial primary completion date: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Apr 10, 2019
P4, N=100, Recruiting, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Completed | Trial completion date: Dec 2019 --> Mar 2020 Trial completion date: Dec 2018 --> Dec 2019 | Trial primary completion date: Nov 2018 --> Nov 2019
- || desoximetasone topical spray / Generic mfg.
Trial primary completion date: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Jan 30, 2018
P4, N=100, Recruiting, Sponsor: Taro Pharmaceuticals USA
Trial completion date: Dec 2018 --> Dec 2019 | Trial primary completion date: Nov 2018 --> Nov 2019 Trial primary completion date: Mar 2019 --> Nov 2018
- | desoximetasone topical spray / Generic mfg.
Trial completion, Trial primary completion date, Adherence: Evaluating Treatment Resistant Dermatitis TaroIIR (clinicaltrials.gov) - Jan 4, 2018
P4, N=24, Completed, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Mar 2019 --> Nov 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jun 2017
- | desoximetasone topical spray / Generic mfg.
Trial primary completion date, Adherence: Evaluating Treatment Resistant Dermatitis TaroIIR (clinicaltrials.gov) - Sep 11, 2017
P4, N=24, Active, not recruiting, Sponsor: Wake Forest University Health Sciences
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Jun 2017 Trial primary completion date: Sep 2017 --> Dec 2017
- | desoximetasone topical spray / Generic mfg.
Enrollment closed, Adherence: Evaluating Treatment Resistant Dermatitis TaroIIR (clinicaltrials.gov) - Jun 14, 2017
P4, N=24, Active, not recruiting, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Sep 2017 --> Dec 2017 Recruiting --> Active, not recruiting
- || desoximetasone topical spray / Generic mfg.
Trial primary completion date: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Mar 20, 2017
P4, N=100, Recruiting, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2017 --> Mar 2019
- | desoximetasone topical spray / Generic mfg.
Enrollment open, Adherence: Evaluating Treatment Resistant Dermatitis TaroIIR (clinicaltrials.gov) - Mar 12, 2017
P4, N=24, Recruiting, Sponsor: Wake Forest University Health Sciences
Trial primary completion date: Dec 2017 --> Mar 2019 Not yet recruiting --> Recruiting
- | desoximetasone topical spray / Generic mfg.
Trial completion: Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray (clinicaltrials.gov) - Mar 3, 2017
P4, N=20, Completed, Sponsor: Psoriasis Treatment Center of Central New Jersey
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- desoximetasone topical spray / Generic mfg.
New P4 trial, Adherence: Evaluating Treatment Resistant Dermatitis TaroIIR (clinicaltrials.gov) - Feb 10, 2017
P4, N=24, Not yet recruiting, Sponsor: Wake Forest University Health Sciences
- || desoximetasone topical spray / Generic mfg.
Trial primary completion date: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Oct 11, 2016
P4, N=100, Recruiting, Sponsor: Taro Pharmaceuticals USA
Active, not recruiting --> Completed Trial primary completion date: Apr 2016 --> Dec 2017
- ||||| desoximetasone topical spray / Generic mfg.
New P4 trial: Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis (clinicaltrials.gov) - Jan 18, 2015
P4, N=100, Recruiting, Sponsor: Taro Pharmaceuticals USA
- ||||||| desoximetasone topical spray / Generic mfg.
Trial completion: Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis (clinicaltrials.gov) - Jan 18, 2012
P3, N=120, Completed, Sponsor: Taro Pharmaceuticals USA
Trial primary completion date: Apr 2016 --> Dec 2017 Recruiting --> Completed
- ||||||| desoximetasone topical spray / Generic mfg.
Trial completion: Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis (clinicaltrials.gov) - Jan 18, 2012
P3, N=120, Completed, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Completed Recruiting --> Completed
- |||| desoximetasone topical spray / Generic mfg.
Trial completion: Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study (clinicaltrials.gov) - Jan 18, 2012
P2, N=151, Completed, Sponsor: Taro Pharmaceuticals USA
Recruiting --> Completed Active, not recruiting --> Completed